The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis

AIMS: The aim of the present meta‐analysis was to evaluate the efficacy and safety of fingolimod in patients with relapsing multiple sclerosis (RMS). METHODS: PubMed, Embase, the Cochrane Library and http://ClinicalTrials.gov were searched for relevant studies. Two authors independently selected the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Clin Pharmacol
Egile Nagusiak: Yang, Ting, Tian, Xin, Chen, Chao‐Yang, Ma, Ling‐Yun, Zhou, Shuang, Li, Min, Wu, Ye, Zhou, Ying, Cui, Yi‐Min
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Systematic Review and Meta‐analysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7098866/
https://ncbi.nlm.nih.gov/pubmed/31869429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14198
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak